Breaking News

Vuzix Cuts Deal with Fortune-100 Pharma Company

Involving the delivery of M300 Smart Glasses

Vuzix Corporation has announced the recent delivery of M300 Smart Glasses to a major Fortune-100 pharmaceutical company.  This transaction represented revenues in the low six figures for Vuzix. 

 

The M300’s will be deployed across 4 continents through numerous use cases including research and development, manufacturing, and logistics. 

 

“We continue to have success with proof-of-concept programs moving towards broader deployment across a variety of different industries,” said Paul Travers, president and chief executive officer at Vuzix. “The successes of initial implementations of the M300 has resulted in a growing pipeline and follow-on orders paving the way for significant adoption within the pharma and life sciences industries as we move into 2018.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters